Regulatory Framework
Regulatory & Safety Notice
Selected References
Regulatory alerts and official databases regarding therapeutic peptides and bulk substances.
U.S. FDA guidance
Certain Bulk Drug Substances for Use in Compounding That May Present Significant Safety Risks
Identifies bulk drug substances that may present significant safety risks in human drug compounding.
U.S. FDA Statement (july 2026)
Revised Draft Product-Specific Guidances for Certain Generic Peptide Products
Updated FDA guidance standards regarding generic peptide therapeutics development and bioequivalence.
Official Database
Drugs@FDA Database Search
Official search portal for FDA-approved drug products, labeling, and regulatory histories.
Therapeutic Goods Administration (June 2026)
Concerns Regarding Unapproved Peptide Products
Public health risks and regulatory warnings concerning unapproved peptide imports and promotion.